AADR vs BIB

Both AADR and BIB are ETFs. AADR has a higher 5-year return than BIB (3.36% vs -4.1%). AADR has a higher expense ratio than BIB (1.1% vs 0.95%). Below is the comparison between AADR and BIB.

AADR BIB
Segment Equity: Global Ex-U.S. - Total Market Growth Leveraged Equity: U.S. Biotech
Issuer AdvisorShares ProShares
Net Assets $69.25M $173.99M
Expense Ratio 1.10% 0.95%
Management Style passive (index-based) passive (index-based)
Dividend Yield 0.68% 0.00%
Underlying Index -- NASDAQ Biotechnology Index
YTD Return -13.66% 10.70%
1-Year Return 3.18% 46.01%
3-Year Return -1.15% 12.22%
5-Year Return 3.36% -4.10%
10-Year Return N/A 26.84%

AADR description

The Fund seeks long-term capital appreciation above international benchmarks such as the MSCI EAFE Index and the BNY Mellon Classic ADR Index. The Fund selects a portfolio of U.S. traded securities of non-U.S. organizations, most often American Depositary Receipts (ADRs), included in the BNY Mellon Classic ADR Index.

AADR performance & returns

YTD Return -13.66%
1-Month Return 6.91%
3-Month Return -17.61%
1-Year Return 3.18%
3-Year Return -1.15%
5-Year Return 3.36%
10-Year Return N/A
AADR expense ratio is 1.1%.

AADR holdings

Top 10 Holdings (41.23% of Total Assets)

Name Symbol % Assets
Galapagos NV ADR GLPG 6.19%
NICE Ltd ADR NICE 5.42%
argenx SE ADR ARGX 4.32%
ZTO Express (Cayman) Inc ADR ZTO 4.04%
TAL Education Group ADR TAL 3.83%
MercadoLibre Inc MELI.SA 3.82%
Anglogold Ashanti Ltd ADR AU.JO 3.45%
ASML Holding NV ADR ASML 3.42%
AstraZeneca PLC ADR AZN.L 3.38%
Gold Fields Ltd ADR GFI.JO 3.36%

Other relevant AADR comparisons

You may also want to check out the following AADR comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

BIB description

The Fund seeks daily investment results, before fees and expenses, that correspond to two times the return of the Nasdaq Biotechnology Index. The Index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical.

BIB performance & returns

YTD Return 10.70%
1-Month Return 29.01%
3-Month Return 8.11%
1-Year Return 46.01%
3-Year Return 12.22%
5-Year Return -4.10%
10-Year Return 26.84%
BIB expense ratio is 0.95%.

BIB holdings

Top 10 Holdings (130.16% of Total Assets)

Name Symbol % Assets
Nasdaq Biotechnology Index Swap Societe Generale N/A 23.75%
Nasdaq Biotechnology Index Swap Bank Of America Na N/A 22.52%
Ishares Biotech (Ibb) Swap Goldman Sachs International N/A 16.59%
Nasdaq Biotechnology Index Swap Ubs Ag N/A 12.89%
Nasdaq Biotechnology Index Swap Citibank Na N/A 12.55%
Nasdaq Biotechnology Index Swap Goldman Sachs International N/A 11.78%
Nasdaq Biotechnology Index Swap Credit Suisse International N/A 8.8%
Gilead Sciences Inc GILD 8.17%
Vertex Pharmaceuticals Inc VRTX 6.76%
Amgen Inc AMGN 6.35%

Other relevant BIB comparisons

You may also want to check out the following BIB comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.
Follow Us